Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 18/20 | 0.66 |
| ▸ | PREP | P48147 | 4/20 | 0.57 |
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.57 |
| ▸ | DPP7 | Q9UHL4 | 3/20 | 0.57 |
| ▸ | FAP | Q12884 | 1/20 | 0.54 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5779937 | 0.80 | DPP4 (1.00) | DPP4PREPDPP8DPP7 | |
| SCHEMBL5777667 | 0.76 | DPP4 (1.00) | DPP4 | |
| SCHEMBL5206757 | 0.75 | DPP4 (1.00) | DPP4PREPDPP8DPP7DPP9 | |
| Hydrochloric Acid SCHEMBL5203352 | 0.74 | DPP4 (0.98) | DPP4PREPDPP8DPP7DPP9 | |
| SCHEMBL5141562 | 0.73 | DPP4 (1.00) | DPP4 | |
| SCHEMBL14619609 | 0.72 | DPP4 (0.67) | DPP4PREPDPP8DPP7DPP9 | |
| SCHEMBL4893429 | 0.72 | DPP4 (1.00) | DPP4PREPDPP8DPP7DPP9 | |
| SCHEMBL14587271 | 0.72 | DPP4 (0.67) | DPP4PREPDPP8DPP7DPP9 | |
| SCHEMBL5217616 | 0.72 | DPP4 (0.67) | DPP4PREPDPP8DPP7DPP9 | |
| Hydrochloric Acid SCHEMBL5217011 | 0.72 | DPP4 (0.66) | DPP4PREPDPP8DPP7DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060293297-A1 | Cyanofluoropyrrolidine derviative | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2006-12-28 | — | — | US | disclosed |
| EP-1627870-A1 | CYANOFLUOROPYRROLIDINE DERIVATIVE | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2006-02-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060293297-A1 | Cyanofluoropyrrolidine derviative | DPP4, DPP3, NPY4R | DPP4 1/4885PREP 618/4885DPP8 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.